Dysbiosis of oral buccal mucosa microbiota in patients with oral lichen planus

Oral Diseases

Volumn 23, Issue 5, 2017, Pages 674-682

  He, Y ^a   Gong, D ^a   Shi, C ^a   Shao, F ^a   Shi, J ^a   Fei, J ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

buccal bacteria dysbiosis; metagenomics; oral lichen planus; pyrosequencing

Indexed keywords

BACTERIAL DNA; DNA 16S;

ACTINOMYCES; ADULT; AGED; ARTICLE; BUCCAL MUCOSA; CONTROLLED STUDY; DNA SEQUENCE; DYSBIOSIS; FEMALE; FUSOBACTERIUM; GENE AMPLIFICATION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; LEPTOTRICHIA; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; MOUTH FLORA; NEISSERIA; NONHUMAN; ORAL BIOPSY; PREVOTELLA; PRIORITY JOURNAL; PROMOTER REGION; STREPTOCOCCUS; VEILLONELLA; BACTERIUM; CASE CONTROL STUDY; COMPLICATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOUTH MUCOSA;

ADULT; AGED; BACTERIA; CASE-CONTROL STUDIES; DYSBIOSIS; FEMALE; HUMANS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA;

EID: 85017367752     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12657     Document Type: Article

References (39)

1. Abusleme L, Dupuy AK, Dutzan N et al (2013). The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J 7: 1016–1025.
2. Attia EAS, Fattah NSAA, Abdella HM (2010). Upper gastrointestinal findings and detection of Helicobacter pylori in patients with oral lichen planus. Clin Exp Dermatol 35: 355–360.
3. Backman K, Jontell M (2007). Microbial-associated oral lichenoid reactions. Oral Dis 13: 402–406.
4. Bashir A, Miskeen AY, Hazari YM, Asrafuzzaman S, Fazili KM (2016). Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut. Tumor Biol 37: 2805–2810.
5. Batu S, Ofluoglu D, Ergun S et al (2016). Evaluation of prolidase activity and oxidative stress in patients with oral lichen planus and oral lichenoid contact reactions. J Oral Pathol Med 45: 281–288.
6. Bornstein MM, Hakimi B, Persson GR (2008). Microbiological findings in subjects with asymptomatic oral lichen planus: a cross-sectional comparative study. J Periodontol 79: 2347–2355.
7. Carbone M, Conrotto D, Carrozzo M, Broccoletti R, Gandolfo S, Scully C (1999). Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis 5: 44–49.
8. Chaushu S, Wilensky A, Gur C et al (2012). Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease. PLoS Pathog 8: e1002601.
9. Couturier MR, Slechta ES, Goulston C, Fisher MA, Hanson KE (2012). Leptotrichia bacteremia in patients receiving high-dose chemotherapy. J Clin Microbiol 50: 1228–1232.
10. Decroix V, Goudjil S, Kongolo G, Mammeri H (2013). ‘Leptotrichia amnionii’, a newly reported cause of early onset neonatal meningitis. J Med Microbiol 62: 785–788.
11. Dethlefsen L, Huse S, Sogin ML, Relman DA (2008). The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6: 2383–2400.
12. Ergun S, Trosala SC, Warnakulasuriya S et al (2011). Evaluation of oxidative stress and antioxidant profile in patients with oral lichen planus. J Oral Pathol Med 40: 286–293.
13. Eribe ERK, Olsen I (2008). Leptotrichia species in human infections. Anaerobe 14: 131–137.
14. Eribe ERK, Paster BJ, Caugant DA et al (2004). Genetic diversity of Leptotrichia and description of Leptotrichia goodfellowii sp nov., Leptotrichia hofstadii sp nov., Leptotrichia shahii sp nov and Leptotrichia wadei sp nov. Int J Syst Evol Microbiol 54: 583–592.
15. Filkins LM, Hampton TH, Gifford AH et al (2012). Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability. J Bacteriol 194: 4709–4717.
16. Georgakopoulou EA, Troupis TG, Troupis G, Gorgoulis VG (2011). Update of the cancer-associated molecular mechanisms in oral lichen planus, a disease with possible premalignant nature. J Buon 16: 613–616.
17. Gur C, Ibrahim Y, Isaacson B et al (2015). Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42: 344–355.
18. Huse SM, Ye Y, Zhou Y, Fodor AA (2012). Core human microbiome as viewed through 16S rRNA sequence clusters. PLoS ONE 7: e34242.
19. Ismail SB, Kumar SKS, Zain RB (2007). Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 49: 89–106.
20. Janardhanam SB, Prakasam S, Swaminathan VT, Kodumudi KN, Zunt SL, Srinivasan M (2012). Differential expression of TLR-2 and TLR-4 in the epithelial cells in oral lichen planus. Arch Oral Biol 57: 495–502.
21. Kazanowska-Dygdala M, Dus I, Radwan-Oczko M (2016). The presence of Helicobacter pylori in oral cavities of patients with leukoplakia and oral lichen planus. J Appl Oral Sci 24: 18–23.
22. Kramer IR, Lucas RB, Pindborg JJ, Sobin LH (1978). Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46: 518–537.
23. Kumagai J, Takiguchi Y, Shono K et al (2013). Acute myelogenous leukemia with Leptotrichia trevisanii bacteremia. Intern Med 52: 2573–2576.
24. Kumar PS, Brooker MR, Dowd SE, Camerlengo T (2011). Target region selection is a critical determinant of community fingerprints generated by 16S pyrosequencing. PLoS ONE 6: e20956.
25. Langfeldt D, Neulinger SC, Stiesch M et al (2014). Health- and disease-associated species clusters in complex natural biofilms determine the innate immune response in oral epithelial cells during biofilm maturation. FEMS Microbiol Lett 360: 137–143.
26. Nobbs AH, Lamont RJ, Jenkinson HF (2009). Streptococcus adherence and colonization. Microbiol Mol Biol Rev 73: 407–450.
27. Ohno S, Tateishi Y, Tatemoto Y, Morishita K, Sasabe E, Yamamoto T (2011). Enhanced expression of Toll-like receptor 2 in lesional tissues and peripheral blood monocytes of patients with oral lichen planus. J Dermatol 38: 324–333.
28. Payeras MR, Cherubini K, Figueiredo MA, Salum FG (2013). Oral lichen planus: focus on etiopathogenesis. Arch Oral Biol 58: 1057–1069.
29. Pourshahidi S, Fakhri F, Ebrahimi H et al (2012). Lack of association between Helicobacter pylori infection and oral lichen planus. Asian Pac J Cancer Prev 13: 1745–1747.
30. Rossmann SN, Wilson PH, Hicks J et al (1998). Isolation of Lautropia mirabilis from oral cavities of human immunodeficiency virus-infected children. J Clin Microbiol 36: 1756–1760.
31. Santagati M, Scillato M, Patane F, Aiello C, Stefani S (2012). Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens. FEMS Immunol Med Microbiol 65: 23–31.
32. Schlosser BJ (2010). Lichen planus and lichenoid reactions of the oral mucosa. Dermatol Ther 23: 251–267.
33. Segata N, Haake SK, Mannon P et al (2012). Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol 13: R42.
34. Siponen M, Kauppila JH, Soini Y, Salo T (2012). TLR4 and TLR9 are induced in oral lichen planus. J Oral Pathol Med 41: 741–747.
35. Stahringer SS, Clemente JC, Corley RP et al (2012). Nurture trumps nature in a longitudinal survey of salivary bacterial communities in twins from early adolescence to early adulthood. Genome Res 22: 2146–2152.
36. Wade WG (2013). The oral microbiome in health and disease. Pharmacol Res 69: 137–143.
37. Wescombe PA, Heng NCK, Burton JP, Chilcott CN, Tagg JR (2009). Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics. Future Microbiol 4: 819–835.
38. Wescombe PA, Hale JDF, Heng NCK, Tagg JR (2012). Developing oral probiotics from Streptococcus salivarius. Future Microbiol 7: 1355–1371.
39. Zhou M, Rong R, Munro D et al (2013). Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing. PLoS ONE 8: e61516.